Novel pro-resolving-medicines in periodontal regeneration

Today during the 43rd Annual Meeting & Exhibition of the American Association for Dental Research, held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, Daniel Huy Nguyen, The Forsyth Institute, Cambridge, Mass., will present research titled "Novel Pro-Resolving-Medicines in Periodontal Regeneration."

Uncontrolled host defense mechanisms can significantly impede tissue engineering, regeneration and reconstruction of oral and craniofacial tissues. The anti-inflammatory and pro-resolving actions of lipoxins and resolvins have already been documented in several preclinical models of including . The aim of this study was to evaluate the potential of Novel Pro-Resolving-Medicines (NPRMs) containing a lipoxin A4 (LXA4) analog in periodontal regeneration.

Polymorphonuclear leukocyte-derived NPRMs were developed to deliver the LXA4-analog to the site of surgery for the purpose of controlling inflammation and promoting tissue and growth. A mini-pig-model of chronic periodontitis was surgically created and progressed into chronic periodontal infrabony defects using wire ligatures. Sites (n=16) were treated with reflection of mucoperiosteal flaps, debridement of the periodontal defect and placement of 1) control, 2) NPRM, 3) LXA4 analog and 4) NPRM+LXA4 analog.

The animals were followed for three months. Clinical evaluations of periodontal measures were obtained and bone blocks were harvested containing surgical sites and subjected to micro-CT, histological and histomorphometric analyses.

Periodic clinical evaluations revealed that LXA4-analog treated groups exhibited complete wound healing with reduced inflammation when compared to control and NRPM-alone. All treatments showed significant pocket depth reductions without any statistical difference. Hematoxylin and Eosin stained sections from NPRM+LXA4 showed a well-organized and newly-formed interproximal bone close to the notch marked at surgery. Linear measurement of the distance between notch and bone crest in NPRM+LXA4 group revealed significant bone fill compared to control (0.6 ± 0.8mm vs. 0.075 ± 0.5mm, respectively; p<0.01). Van Gieson-stained undecalcified sections demonstrated similar findings with new bone and new connective tissue formation at the NPRM+LXA4-treated sites. Further, micro-CT reconstruction of 3D morphology revealed complex anatomical structure and guided histological evaluation.

More information: This is a summary of abstract #755, "Novel Pro-Resolving-Medicines in Periodontal Regeneration," which will be presented on Friday, March 21, 2014, 8 a.m. – 9:30 a.m. at the Charlotte Convention Center, room 203A.

Provided by International & American Associations for Dental Research

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Topical treatment shows potential for infantile eczema

Aug 08, 2012

(HealthDay) -- Ten days of treatment with a cream containing 15(R/S)-methyl-lipoxin A4 (LXA4) is well tolerated and reduces the severity of infantile eczema, according to a study published online July 26 in the ...

Study links tooth loss to depression and anxiety

Mar 20, 2014

Today, at the 43rd Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, R. Constance Wiener, ...

Recommended for you

Roman-Britons had less gum disease than modern Britons

Oct 23, 2014

The Roman-British population from c. 200-400 AD appears to have had far less gum disease than we have today, according to a study of skulls at the Natural History Museum led by a King's College London periodontist. The surprise ...

Want whiter teeth? Fruit mixture is not the answer

Oct 14, 2014

Can you ditch the strips and dump the dentist for whiter teeth? From "The Dr. Oz Show" to YouTube videos, experts say you can reclaim those pearly whites simply by mixing fruit, such as strawberries, with ...

User comments